JP2004535195A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004535195A5 JP2004535195A5 JP2003507263A JP2003507263A JP2004535195A5 JP 2004535195 A5 JP2004535195 A5 JP 2004535195A5 JP 2003507263 A JP2003507263 A JP 2003507263A JP 2003507263 A JP2003507263 A JP 2003507263A JP 2004535195 A5 JP2004535195 A5 JP 2004535195A5
- Authority
- JP
- Japan
- Prior art keywords
- fusion protein
- slyd
- fkpa
- group
- fkbp chaperone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 10
- 108020001507 fusion proteins Proteins 0.000 claims 6
- 102000037865 fusion proteins Human genes 0.000 claims 6
- 229920001184 polypeptide Polymers 0.000 claims 6
- 102000004196 processed proteins & peptides Human genes 0.000 claims 6
- 108010006519 Molecular Chaperones Proteins 0.000 claims 5
- 102000018679 Tacrolimus Binding Proteins Human genes 0.000 claims 5
- 108010027179 Tacrolimus Binding Proteins Proteins 0.000 claims 5
- 102000053602 DNA Human genes 0.000 claims 3
- 108020004511 Recombinant DNA Proteins 0.000 claims 3
- 101710154918 Trigger factor Proteins 0.000 claims 3
- 150000001413 amino acids Chemical class 0.000 claims 2
- 239000002773 nucleotide Substances 0.000 claims 2
- 125000003729 nucleotide group Chemical group 0.000 claims 2
- 241001465754 Metazoa Species 0.000 claims 1
- 239000013604 expression vector Substances 0.000 claims 1
- 230000003053 immunization Effects 0.000 claims 1
- 238000002649 immunization Methods 0.000 claims 1
- 238000003018 immunoassay Methods 0.000 claims 1
- 238000011144 upstream manufacturing Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01115225 | 2001-06-22 | ||
| EP01120939 | 2001-08-31 | ||
| PCT/EP2002/006957 WO2003000878A2 (en) | 2001-06-22 | 2002-06-24 | Use of fkbp chaperones as expression tool |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006326846A Division JP4309910B2 (ja) | 2001-06-22 | 2006-12-04 | 発現ツールとしてのｆｋｂｐシャペロンの使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004535195A JP2004535195A (ja) | 2004-11-25 |
| JP2004535195A5 true JP2004535195A5 (https=) | 2005-08-25 |
| JP4174422B2 JP4174422B2 (ja) | 2008-10-29 |
Family
ID=26076626
Family Applications (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003507263A Expired - Fee Related JP4174422B2 (ja) | 2001-06-22 | 2002-06-24 | 発現ツールとしてのｆｋｂｐシャペロンの使用 |
| JP2003507262A Expired - Fee Related JP4262594B2 (ja) | 2001-06-22 | 2002-06-24 | レトロウイルス表面糖タンパク質を含む可溶性複合体 |
| JP2006326846A Expired - Fee Related JP4309910B2 (ja) | 2001-06-22 | 2006-12-04 | 発現ツールとしてのｆｋｂｐシャペロンの使用 |
| JP2007183508A Expired - Fee Related JP4320351B2 (ja) | 2001-06-22 | 2007-07-12 | レトロウイルス表面糖タンパク質を含む可溶性複合体 |
| JP2008286959A Withdrawn JP2009102320A (ja) | 2001-06-22 | 2008-11-07 | レトロウイルス表面糖タンパク質を含む可溶性複合体 |
| JP2009025509A Expired - Fee Related JP4523660B2 (ja) | 2001-06-22 | 2009-02-06 | 発現ツールとしてのｆｋｂｐシャペロンの使用 |
Family Applications After (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003507262A Expired - Fee Related JP4262594B2 (ja) | 2001-06-22 | 2002-06-24 | レトロウイルス表面糖タンパク質を含む可溶性複合体 |
| JP2006326846A Expired - Fee Related JP4309910B2 (ja) | 2001-06-22 | 2006-12-04 | 発現ツールとしてのｆｋｂｐシャペロンの使用 |
| JP2007183508A Expired - Fee Related JP4320351B2 (ja) | 2001-06-22 | 2007-07-12 | レトロウイルス表面糖タンパク質を含む可溶性複合体 |
| JP2008286959A Withdrawn JP2009102320A (ja) | 2001-06-22 | 2008-11-07 | レトロウイルス表面糖タンパク質を含む可溶性複合体 |
| JP2009025509A Expired - Fee Related JP4523660B2 (ja) | 2001-06-22 | 2009-02-06 | 発現ツールとしてのｆｋｂｐシャペロンの使用 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US7244819B2 (https=) |
| EP (3) | EP2267452B8 (https=) |
| JP (6) | JP4174422B2 (https=) |
| KR (2) | KR100702373B1 (https=) |
| CN (1) | CN100510068C (https=) |
| AT (2) | ATE522603T1 (https=) |
| AU (2) | AU2002317841A1 (https=) |
| BR (1) | BRPI0210598B8 (https=) |
| CA (3) | CA2770453C (https=) |
| DE (1) | DE60233942D1 (https=) |
| DK (2) | DK1402015T3 (https=) |
| ES (3) | ES2391623T3 (https=) |
| MX (1) | MXPA03011455A (https=) |
| PL (2) | PL215170B1 (https=) |
| WO (2) | WO2003000877A2 (https=) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA03011455A (es) * | 2001-06-22 | 2004-04-05 | Hoffmann La Roche | Complejo soluble que comprende glucoproteina de superficie retroviral. |
| EP1516928B1 (en) * | 2002-06-25 | 2010-02-17 | Sekisui Chemical Co., Ltd. | Expression vector, host, fused protein, process for producing fused protein and process for producing protein |
| DK1567195T3 (da) * | 2002-11-26 | 2011-02-14 | Upfront Chromatography As | Dendrimerkonjugater til selektiv opløsning af proteinaggregater |
| AU2004230803A1 (en) * | 2003-04-18 | 2004-10-28 | Chiba, Joe | Immunogen, composition for immunological use and process for producing antibody using the same |
| US9057061B2 (en) * | 2003-12-23 | 2015-06-16 | Novozymes Biopharma Dk A/S | Gene expression technique |
| US7604935B2 (en) | 2005-10-26 | 2009-10-20 | Roche Diagnostics Operations, Inc. | Soluble rubella E1 envelope protein variants |
| WO2007077008A1 (en) | 2006-01-03 | 2007-07-12 | Roche Diagnostics Gmbh | Chimaeric fusion protein with superior chaperone and folding activities |
| WO2007141650A2 (en) * | 2006-01-17 | 2007-12-13 | Instituto De Medicina Molecular | Compositions and methods for diagnosing hiv-2 infection |
| JP2009536958A (ja) | 2006-05-11 | 2009-10-22 | ベクトン・ディキンソン・アンド・カンパニー | 細胞からのタンパク質抽出方法 |
| GB0611405D0 (en) | 2006-06-09 | 2006-07-19 | Univ Belfast | FKBP-L: A novel inhibitor of angiogenesis |
| ATE529436T1 (de) | 2007-04-20 | 2011-11-15 | Hoffmann La Roche | Erkennung von primären infektionen mit krankheitserregern |
| WO2009031852A2 (en) * | 2007-09-06 | 2009-03-12 | Korea University Industry and Academy Cooperation Foundation | Preparation method of recombinant protein by use of a fusion expression partner |
| US9207240B2 (en) | 2007-11-14 | 2015-12-08 | Arbor Vita Corporation | Method of efficient extraction of protein from cells |
| ES2450998T3 (es) | 2007-12-13 | 2014-03-26 | F. Hoffmann-La Roche Ag | Nuevas variantes de proteína de cubierta E1 de rubéola y su utilización en la detección de anticuerpos anti-rubéola |
| EP2127678A1 (en) | 2008-05-26 | 2009-12-02 | Roche Diagnostics GmbH | SlpA as a tool for recombinant protein and enzyme technology |
| AU2011230619C1 (en) | 2010-03-25 | 2016-06-23 | Oregon Health & Science University | CMV glycoproteins and recombinant vectors |
| AU2012212047A1 (en) * | 2011-02-03 | 2013-08-22 | Xoma Technology Ltd. | Methods and materials for enhancing functional protein expression in bacteria |
| AR086250A1 (es) | 2011-05-05 | 2013-11-27 | Hoffmann La Roche | Polipeptido de fusion presentador de una secuencia de aminoacidos y utilizacion del mismo |
| HUE037408T2 (hu) | 2011-06-10 | 2018-08-28 | Univ Oregon Health & Science | CMV glikoproteinek és rekombináns vektorok |
| CA2789539A1 (en) | 2011-09-12 | 2013-03-12 | International Aids Vaccine Initiative | Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies |
| US9402894B2 (en) | 2011-10-27 | 2016-08-02 | International Aids Vaccine Initiative | Viral particles derived from an enveloped virus |
| EP2617731A1 (en) | 2012-01-19 | 2013-07-24 | Roche Diagnostics GmbH | Soluble immunoreactive Treponema pallidum TpN47 antigens |
| ES2631608T3 (es) | 2012-06-27 | 2017-09-01 | International Aids Vaccine Initiative | Variante de la glicoproteína Env del VIH-1 |
| EP2706115A1 (en) | 2012-09-06 | 2014-03-12 | Roche Diagnostics GmbH | Chaperone-chaperone fusion polypeptides for reduction of interference and stabilization of immunoassays |
| AR093778A1 (es) | 2012-11-08 | 2015-06-24 | Hoffmann La Roche | PROTEINAS LIGANTES DE ANTIGENO ANTI-HER3/HER4 DE UNION A LA HORQUILLA b DE HER3 Y A LA HORQUILLA b DE HER4 |
| MA38165A1 (fr) | 2012-11-08 | 2018-07-31 | Hoffmann La Roche | Protéines de liaison à l'antigène her3 se liant à l'épingle à cheveux beta de her3 |
| ES2603589T3 (es) | 2012-11-08 | 2017-02-28 | F. Hoffmann-La Roche Ag | Ácidos nucleicos que codifican polipéptidos quiméricos para la identificación sistemática de bibliotecas |
| EP2827146A1 (en) | 2013-07-18 | 2015-01-21 | Roche Diagnostics GmbH | Vibrio cholerae lipoprotein 15 (Lp15) variants as anti-interference additive in TpN17-based immunoassays for detection of anti-Treponema antibodies |
| EP2848937A1 (en) | 2013-09-05 | 2015-03-18 | International Aids Vaccine Initiative | Methods of identifying novel HIV-1 immunogens |
| WO2015044083A1 (en) * | 2013-09-27 | 2015-04-02 | F. Hoffmann-La Roche Ag | Thermus thermophilus slyd fkbp domain specific antibodies |
| US10058604B2 (en) | 2013-10-07 | 2018-08-28 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
| EP2913338A1 (en) | 2014-02-28 | 2015-09-02 | Roche Diagniostics GmbH | Soluable and immunoreactive variants of HTLV capsid antigen p24 |
| JP2015215244A (ja) * | 2014-05-12 | 2015-12-03 | 富士レビオ株式会社 | 免疫測定における抗ｈｔｌｖ抗体の検出感度を向上させる方法 |
| MX2016014416A (es) | 2014-05-14 | 2017-02-23 | Hoffmann La Roche | Anticuerpos anti-her3 que se unen a la horquilla beta de her3. |
| BR112016025056A2 (pt) | 2014-05-14 | 2018-02-20 | F. Hoffmann-La Roche Ag | uso de pelo menos um polipeptídeo, anticorpo biespecífico, anticorpo biespecífico isolado, anticorpo her3/her2 biespecífico, célula hospedeira, método de produção do anticorpo biespecífico her3/her2, imunoconjugado e formulação farmacêutica |
| CN107532190B (zh) | 2014-12-01 | 2021-07-09 | 菲尼克斯公司 | 用于肽生产的融合伴侣 |
| CA2974343A1 (en) * | 2015-02-13 | 2016-08-18 | Sekisui Chemical Co., Ltd. | Nucleic acid, fusion protein, recombined cell, and isoprene or cyclic terpene production method |
| EP3069730A3 (en) | 2015-03-20 | 2017-03-15 | International Aids Vaccine Initiative | Soluble hiv-1 envelope glycoprotein trimers |
| US9931394B2 (en) | 2015-03-23 | 2018-04-03 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
| JP6967002B2 (ja) * | 2015-12-15 | 2021-11-17 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | トランスグルタミナーゼ認識部位を有するｆｋｂｐドメイン |
| ES2796479T3 (es) | 2016-05-31 | 2020-11-27 | Hoffmann La Roche | Procedimiento de pretratamiento para la detección rápida del antígeno central del VHC |
| JP2019523863A (ja) | 2016-05-31 | 2019-08-29 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | ウイルス抗原の血清学的検出方法 |
| EP3472322B1 (en) * | 2016-06-20 | 2022-01-05 | MetGen Oy | Method for obtaining active insoluble xylose isomerase |
| JP7068323B2 (ja) | 2017-02-02 | 2022-05-16 | エフ．ホフマン－ラ ロシュ アーゲー | 少なくとも２種のペグ化された分析物特異的結合剤を使用する免疫アッセイ |
| CN110709410B (zh) | 2017-04-26 | 2024-07-02 | 豪夫迈·罗氏有限公司 | 可溶性和免疫反应性寨卡病毒ns1多肽 |
| CN110996986B (zh) | 2017-07-27 | 2024-07-19 | 豪夫迈·罗氏有限公司 | Hcv抗原的多表位融合蛋白及其用途 |
| CN110066343B (zh) * | 2019-05-23 | 2021-04-09 | 北京新创生物工程有限公司 | 一种用于检测hiv新发感染的重组抗原及其应用 |
| CN115843334B (zh) | 2020-04-23 | 2026-01-13 | 豪夫迈·罗氏有限公司 | 用于抗体免疫测定的冠状核衣壳抗原 |
| WO2023012321A1 (en) | 2021-08-06 | 2023-02-09 | Roche Diagnostics Gmbh | Chimeric igg-fc-binding ligand polypeptide and uses thereof for igg affinity purification |
| US20250298022A1 (en) | 2022-05-03 | 2025-09-25 | Roche Diagnostics Operations, Inc. | Hiv gp41 variants for immunodiagnostic assays |
| WO2025098623A1 (en) | 2023-11-09 | 2025-05-15 | Roche Diagnostics Gmbh | Transglutaminase substrates for labeling |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2095818B (en) | 1981-03-27 | 1985-10-02 | Exxon Research Engineering Co | Staged adsorption/resorption heat pump |
| US4735896A (en) | 1986-03-04 | 1988-04-05 | United Biomedical, Inc. | Synthetic peptide and process of using same for the detection and diagnosis of AIDS and pre-AIDS conditions |
| US4879212A (en) | 1986-04-02 | 1989-11-07 | United Biomedical Inc. | Peptide composition and method for the detection of antibodies to HTLV-III |
| US6024983A (en) | 1986-10-24 | 2000-02-15 | Southern Research Institute | Composition for delivering bioactive agents for immune response and its preparation |
| DE3705686C2 (de) | 1987-02-23 | 1995-11-30 | Boehringer Mannheim Gmbh | Verfahren zur Bestimmung von Antikörpern |
| NZ224663A (en) | 1987-05-28 | 1990-11-27 | Amrad Corp Ltd | Fusion proteins containing glutathione-s-transferase and expression of foreign polypeptides using glutathione-s-transferase encoding vectors |
| SE8704185L (sv) | 1987-10-28 | 1989-04-29 | Ferring Ab | Nya peptider, artificiella antigener och immunoanalystestsatser |
| CA2003383A1 (en) * | 1988-11-23 | 1990-05-23 | Sushil G. Devare | Synthetic dna derived recombinant hiv antigens |
| ATE160358T1 (de) | 1991-06-14 | 1997-12-15 | St Vincents Inst Med Res | Detektion des immunschwäche-virus aus felis |
| WO1993013200A1 (en) * | 1991-12-20 | 1993-07-08 | Novo Nordisk A/S | A process for the preparation of lipase |
| JP2001504572A (ja) | 1992-04-09 | 2001-04-03 | アボツト・ラボラトリーズ | Ｈｉｖ抗原及びｈｉｖ抗体を検出するためのアッセイ |
| WO1993025533A1 (en) | 1992-06-05 | 1993-12-23 | Abbott Laboratories | Methods and reagents for the determination of immunosuppressive agents |
| ATE195347T1 (de) | 1992-10-02 | 2000-08-15 | Res Corp Technologies Inc | Methoden der erhöhung der sekretion von überexpremierten proteinen |
| US5459051A (en) | 1993-03-26 | 1995-10-17 | Celtrix Pharmaceuticals, Inc. | Methods and vectors for over-expression of ubiquitin fusion proteins in host cells |
| DE4428705A1 (de) * | 1994-08-12 | 1996-02-15 | Boehringer Mannheim Gmbh | Rekombinantes Antigen aus der NS3-Region des Hepatitis C Virus |
| AU3968595A (en) | 1994-10-25 | 1996-05-15 | Board Of Trustees Of The Leland Stanford Junior University | Conditional transformation of genetically engineered cells |
| WO1996041865A1 (en) | 1995-06-07 | 1996-12-27 | Ariad Gene Therapeutics, Inc. | Rapamcycin-based regulation of biological events |
| WO1997010502A1 (en) | 1995-09-15 | 1997-03-20 | Merck & Co., Inc. | A high throughput assay using fusion proteins |
| US5723125A (en) * | 1995-12-28 | 1998-03-03 | Tanox Biosystems, Inc. | Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide |
| GB9614114D0 (en) | 1996-07-05 | 1996-09-04 | Amcor Packaging Uk Ltd | New packages |
| JP2001501093A (ja) | 1996-09-26 | 2001-01-30 | メディカル リサーチ カウンシル | シャペロン断片 |
| US6225082B1 (en) * | 1997-05-09 | 2001-05-01 | Research Corporation Technologies, Inc. | Myelin basic protein MRNA transport and translation enhancer sequences |
| US5989868A (en) * | 1997-09-12 | 1999-11-23 | The Board Of Regents Of The University Of Oklahoma | Fusion protein systems designed to increase soluble cytoplasmic expression of heterologous proteins in esherichia coli |
| JP2002508971A (ja) | 1998-01-15 | 2002-03-26 | アリアド・ジーン・セラピューティクス・インコーポレーテッド | 多量体キメラ蛋白質を使用する生物学的イベントの調節 |
| DE19913117A1 (de) * | 1998-05-06 | 1999-11-11 | Roche Diagnostics Gmbh | Entstörung durch Rheumafaktoren |
| US6248329B1 (en) * | 1998-06-01 | 2001-06-19 | Ramaswamy Chandrashekar | Parasitic helminth cuticlin nucleic acid molecules and uses thereof |
| ATE473755T1 (de) | 1998-10-02 | 2010-07-15 | Rhein Biotech Proz & Prod Gmbh | Methode zur herstellung von (poly)peptiden unter verwendung von verkürzten varianten von sv40 large t antigen mit einem intakten n terminus |
| EP1127140A2 (en) | 1998-11-06 | 2001-08-29 | President And Fellows Of Harvard College | Fk506-based regulation of biological events |
| AU3305100A (en) | 1999-03-17 | 2000-10-04 | Medical Research Council | Method for refolding molecules of polypeptides containing ig domains |
| AU4933200A (en) | 1999-05-14 | 2000-12-05 | Medical Research Council | Oligomeric chaperone proteins |
| GB9913437D0 (en) | 1999-06-09 | 1999-08-11 | Medical Res Council | Fusion proteins |
| EP1077263A1 (de) * | 1999-07-29 | 2001-02-21 | F.Hoffmann-La Roche Ag | Verfahren zur Herstellung von natürlich gefalteten und sekretierten Proteinen durch Co-Sekretion von Chaperonen |
| CA2403718A1 (en) * | 2000-03-17 | 2001-09-27 | Panacos Pharmaceuticals, Inc. | A method for generating immunogens that elicit neutralizing antibodies against fusion-active regions of hiv envelope proteins |
| JP2002262883A (ja) * | 2001-03-13 | 2002-09-17 | Sekisui Chem Co Ltd | モノクローナル抗体の製造方法 |
| MXPA03011455A (es) * | 2001-06-22 | 2004-04-05 | Hoffmann La Roche | Complejo soluble que comprende glucoproteina de superficie retroviral. |
-
2002
- 2002-06-24 MX MXPA03011455A patent/MXPA03011455A/es active IP Right Grant
- 2002-06-24 KR KR1020037016770A patent/KR100702373B1/ko not_active Expired - Fee Related
- 2002-06-24 PL PL367679A patent/PL215170B1/pl unknown
- 2002-06-24 EP EP10173342A patent/EP2267452B8/en not_active Expired - Lifetime
- 2002-06-24 DE DE60233942T patent/DE60233942D1/de not_active Expired - Lifetime
- 2002-06-24 AU AU2002317841A patent/AU2002317841A1/en not_active Abandoned
- 2002-06-24 DK DK02758265.9T patent/DK1402015T3/da active
- 2002-06-24 EP EP02747428A patent/EP1402041B1/en not_active Expired - Lifetime
- 2002-06-24 ES ES10173342T patent/ES2391623T3/es not_active Expired - Lifetime
- 2002-06-24 ES ES02758265T patent/ES2372031T3/es not_active Expired - Lifetime
- 2002-06-24 PL PL397776A patent/PL218245B1/pl unknown
- 2002-06-24 US US10/179,038 patent/US7244819B2/en not_active Expired - Lifetime
- 2002-06-24 KR KR1020067005314A patent/KR100611545B1/ko not_active Expired - Fee Related
- 2002-06-24 CA CA2770453A patent/CA2770453C/en not_active Expired - Fee Related
- 2002-06-24 DK DK10173342.6T patent/DK2267452T3/da active
- 2002-06-24 WO PCT/EP2002/006956 patent/WO2003000877A2/en not_active Ceased
- 2002-06-24 BR BR0210598-5 patent/BRPI0210598B8/pt not_active IP Right Cessation
- 2002-06-24 AU AU2002325265A patent/AU2002325265B2/en not_active Expired
- 2002-06-24 CN CNB028124715A patent/CN100510068C/zh not_active Expired - Lifetime
- 2002-06-24 AT AT02758265T patent/ATE522603T1/de active
- 2002-06-24 AT AT02747428T patent/ATE445016T1/de active
- 2002-06-24 CA CA2449747A patent/CA2449747C/en not_active Expired - Lifetime
- 2002-06-24 ES ES02747428T patent/ES2333108T3/es not_active Expired - Lifetime
- 2002-06-24 CA CA2450476A patent/CA2450476C/en not_active Expired - Lifetime
- 2002-06-24 EP EP02758265A patent/EP1402015B1/en not_active Expired - Lifetime
- 2002-06-24 JP JP2003507263A patent/JP4174422B2/ja not_active Expired - Fee Related
- 2002-06-24 JP JP2003507262A patent/JP4262594B2/ja not_active Expired - Fee Related
- 2002-06-24 WO PCT/EP2002/006957 patent/WO2003000878A2/en not_active Ceased
-
2006
- 2006-12-04 JP JP2006326846A patent/JP4309910B2/ja not_active Expired - Fee Related
-
2007
- 2007-04-13 US US11/786,847 patent/US8426167B2/en not_active Expired - Fee Related
- 2007-07-12 JP JP2007183508A patent/JP4320351B2/ja not_active Expired - Fee Related
-
2008
- 2008-11-07 JP JP2008286959A patent/JP2009102320A/ja not_active Withdrawn
-
2009
- 2009-02-06 JP JP2009025509A patent/JP4523660B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004535195A5 (https=) | ||
| CA2449747A1 (en) | Use of fkbp chaperones as expression tool | |
| Bordo et al. | The role of side-chain hydrogen bonds in the formation and stabilization of secondary structure in soluble proteins | |
| JP2005120106A5 (https=) | ||
| JP2018171063A5 (https=) | ||
| Lupas | Coiled coils: new structures and new functions | |
| JP2010529860A5 (https=) | ||
| NZ597685A (en) | Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli | |
| JP2015212284A5 (https=) | ||
| DK1133565T3 (da) | Generering af specifikke bindingspartnere til (poly)peptider, som der kodes for af genomiske DNA-fragmenter eller EST'er | |
| JP2024041747A5 (https=) | ||
| CA2636075A1 (en) | Chimaeric fusion protein with superior chaperone and folding activities | |
| DE69033453D1 (de) | Rekombinante Polypeptide und Peptide, dafür kodierende Nukleinsäuren und ihre Verwendung in der Tuberkulose-Diagnose | |
| JP2006514820A5 (https=) | ||
| HRP20161449T1 (hr) | Genski proizvodi koji su diferecijalno izraženi u tumorima i njihova primjena | |
| Müller et al. | [17] Protein fusions to coiled-coil domains | |
| US11085038B2 (en) | Polypeptide library | |
| EP4216994A1 (en) | Multimeric protein complexes as antibody substitutes for neutralization of viral pathogens in prophylactic and therapeutic applications | |
| CA2562738A1 (en) | Soluble rubella e1 envelope antigens | |
| JP2008509077A (ja) | Ｃ５ａ受容体を遮断する化合物および治療法におけるその使用 | |
| CA2519993A1 (en) | Ph-dependent polypeptide aggregation and its use | |
| Dzionara et al. | Prediction for secondary structures of ten proteins from the 50S subunit of the escherichia coli ribosome | |
| JP2023057069A5 (https=) | ||
| WO2004056316A3 (en) | Vaccines against hiv-1 tat protein to generate neutralizing antibodies | |
| NO20006456L (no) | En mutant human hepatitt B viral stamme og anvendelser derav |